Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 10

Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease

Pages
804–810
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

VNS merits further study for its potentially favorable effects on cardiovascular disease, especially heart failure

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The vagus nerve is a major component of the autonomic nervous system and plays a critical role in many body functions including for example, speech, swallowing, heart rate and respiratory control, gastric secretion, and intestinal motility.
📊
Key Findings & Data:Vagus nerve stimulation (VNS) refers to any technique that stimulates the vagus nerve, with electrical stimulation being the most important.
💡
Conclusion & Impact:VNS merits further study for its potentially favorable effects on cardiovascular disease, especially heart failure
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The vagus nerve is a major component of the autonomic nervous system and plays a critical role in many body functions including for example, speech, swallowing, heart rate and respiratory control, gastric secretion, and intestinal motility. Vagus nerve stimulation (VNS) refers to any technique that stimulates the vagus nerve, with electrical stimulation being the most important. Implantable devices for VNS are approved therapy for refractory epilepsy and for treatment-resistant depression. In the case of heart disease applications, implantable VNS has been shown to be beneficial for treating heart failure in both preclinical and clinical studies. Adverse effects of implantable VNS therapy systems are generally associated with the implantation procedure or continuous on-off stimulation. The most serious implantation-associated adverse effect is infection. The effectiveness of non-invasive transcutaneous VNS for epilepsy, depression, primary headaches, heart failure, and other conditions remains under investigation. VNS merits further study for its potentially favorable effects on cardiovascular disease, especially heart failure

🔖

Cite This Article

AKDEMİR, B., BENDİTT, D. G. (2016). Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 10, 804–810. https://ajindex.com/articles/366732

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Benditt DG, Iskos D, Sakaguchi S. Autonomic nervous system and cardiac arrhythmias. In. Electrophysiological Discorders of the Heart. (eds. Sakasena S and Camm AJ) Philedelphia, PA, Elsevier Chrchill Livingstone 2005.p. 49-67.
  2. Ermiş C, Benditt DG. Carotid sinus massage during evaluation for transient loss of consciousness: just a positive test. Europace 2004; 6: 292-5.
  3. Benditt DG, Lurie KG, Fahy G, Iskos D, Sakaguchi S. Treatment of vasovagal syncope: Is there a role for cardiac pacing? In. Non- pharmacological Therapy of Arrhythmias for the 21st Centrury: The State of the Art (eds. Singer I, Barold SS, Camm AJ) Armonk, NY, Futura Publishing Co, Inc., 1998.p. 881-9.
  4. Benditt DG, Sakaguchi S, van Dijk JG. Autonomic Nervous System and Cardiac Arrhythmias. In. Electrophysiology Disorders of the Heart 2nd edition. Saksena S, Camm AJ, Boyden PA, Dorian P, Gold- schlager N, Vetter, Zareba W (eds). Elsevier Sauders, Philadelphia, 2012. p. 61-71.
  5. Benditt DG, Samniah N, Fahy GJ, Lurie KG, Sakaguchi S. Atrial Fi- brillation: defining potential curative ablation targets. J Interv Card VNS: vagus nerve stimulation 12 months (%) 21 15 1.5 62 16 13 2.3 17 15 4.7 Electrophysiol 2000; 4: 141-7.
  6. Lu F, Adkisson WO, Chen T, Akdemir B, Benditt DG. Catheter abla- tion for long-standing persistent atrial fibrillation in patients who have failed electrical cardioversion. J Cardiovasc Transl Res 2013; 6: 278-86.
  7. Almquist A, Gornick C, Benson WJr, Dunnigan A, Benditt DG. Ca- rotid sinus hypersensitivity: evaluation of the vasodepressor com- ponent. Circulation 1985; 71: 927-36.
  8. Reiter MJ, Stromberg KD, Whitman TA, Adamson PB, Benditt DG, Gold MR. Influence of intra-cardiac pressure on spontaneous ven- tricular arrhythmias in patients with systolic heart failure: Insights from the REDUCEhf trial. Circ Arrhythm Electrophysiol 2013; 6: 272-8.
  9. Ben-Menachem E, Revesz D, Simon BJ, Silberstein S. Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. Eur J Neurol 2015; 22: 1260-8. Lanska JL. Corning and vagal nerve stimulation for seizures in the 1880s. Neurology 2002; 58: 452-9.
  10. Lockard JS, Congdon WC, DuCharme LL. Feasibility and safety of vagal stimulation in monkey model. Epilepsia 1990; 31 (Suppl. 2): S20-6. Woodbury JW, Woodbury DM. Vagal stimulation reduces the sever- ity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording. Pacing Clin Electrophysiol 1991; 14: 94-107. Ben-Mena